📰 Lobe Sciences Ltd News
Page 5 - Lobe Sciences Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lobe Sciences Ltd. Real-time updates on events, politics, business and more.
September 2, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
September 1, 2022
Psychedelics biopharma company Lobe Sciences Ltd. (OTCQB:LOBEF) signed a deal with Cantheon Capital, a development of cannabinoids and psyche...
September 1, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
September 1, 2022
“The opportunity to advance our proprietary psilocin compounds in multiple human trials puts Lobe in a leading position within the...
September 1, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
August 19, 2022
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
August 10, 2022
Banxa Holdings Inc has announced that its founder and chairman, Domenic Carosa, will be attending the Q3 Virtual Investor Summit on August 16 and 17, 2022,...
August 10, 2022
Banxa Holdings Inc has announced that its founder and chairman, Domenic Carosa, will be attending the Q3 Virtual Investor Summit on August 16 and 17, 2022,...
August 10, 2022
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
July 19, 2022
"Our patent portfolio now consists of multiple patent filings for the use and delivery of psilocybin, psilocin analogues and N-Acetyl...